SCHEMBL25211481

SCHEMBL25211481

CC1(C)CNC(=O)c2ccc(-c3c[nH]c4nc(N)ncc34)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 4/20 0.38
▸ KIT P10721 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAP3K11 Q16584 1/20 0.37
▸ CCNT1 O60563 10/20 0.37
▸ CCNA2 P20248 10/20 0.37
▸ CDK2 P24941 10/20 0.37
▸ CDK9 P50750 10/20 0.37
▸ LCK P06239 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ PRKCQ Q04759 1/20 0.37
▸ CCNA1 P78396 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ MAPKAPK2 P49137 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30407400 1.00 CDC7 (0.38) CDC7KITCYP3A4CYP2D6MAP3K11
SCHEMBL25158460 0.88 PRKCQ (0.37) CDC7KITMAP3K11CDK9PRKCQ
SCHEMBL30347902 0.87 BRD4 (0.46) CDC7PRKCQPIM1PIM3PIM2
SCHEMBL25158906 0.87 BRD4 (0.46) CDC7PRKCQPIM1PIM3PIM2
SCHEMBL25222156 0.85 PRKCQ (0.40) CDC7KITPRKCQ
SCHEMBL30407676 0.85 PRKCQ (0.40) CDC7KITPRKCQ
SCHEMBL30347725 0.85 CAMKK2 (0.36) CDC7PRKCQPIM1PIM3PIM2
SCHEMBL25225794 0.85 CAMKK2 (0.36) CDC7PRKCQPIM1PIM3PIM2
SCHEMBL25158848 0.84 PRKCQ (0.38) CDC7MAP3K11PRKCQ
SCHEMBL25158909 0.84 PRKCQ (0.38) CDC7KITMAP3K11CDK2PRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US claimed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 CDC7 345/4885KIT 4649/4885CYP3A4 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback